PCR.AI

by diagnostics.ai  · Based in United Kingdom → — Automated analysis reporting and QC for PCR testing
Infectious Disease Laboratory Medicine Pathology

Tiered pricing model, subscription-based for device manager, combination of deployment scope and implementation services for enterprise edition, partnership model for oem partners.
Regulatory Status Disclosed

Overview

PCR.AI is an AI-powered platform that automates the analysis, quality control, and reporting of real-time PCR data. It uses advanced machine learning algorithms to interpret fluorescence curves, automatically classifies results, applies quality control checks, and generates standardized reports. The system aims to improve accuracy while dramatically reducing the time required for manual analysis. diagnostics.ai, founded in 2009, developed PCR.AI with a mission to address patient safety issues in diagnostic testing by leveraging data science, AI, and machine learning to enhance diagnostic accuracy, reduce costs, and improve global patient safety.

The core of PCR.AI’s innovation lies in its internationally patented AI-based learning machines. These algorithms replicate the decision-making process of expert clinical technicians, automating routine analyses and eliminating manual steps in patient testing. The technology, as showcased in PCR.AI, boasts an interpretation accuracy exceeding 99.9%, validated in multiple independent studies involving over 0.25 million samples. This performance has been validated across various assay types, instruments, and laboratory settings.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-Powered Curve Validation
  • Automated Run Settings Verification
  • Advanced Quality Control (Westgard & Levey-Jennings)
  • Seamless LIMS Integration
  • Real-Time Trend Issue Alerting
  • Sample Type Recognition
  • Intelligent Rules Engine
  • Precision Quantification
  • Comprehensive Audit Trails
  • Continuous AI Learning

Use Cases

  • Automating real-time qPCR curve analysis and interpretation
  • Applying Westgard, Levey-Jennings, and other QC standards
  • Generating audit-ready reports for clinical compliance
  • Integrating AI-interpreted results directly with LIMS systems
  • Reducing complexity of qPCR analysis and need for specialists
  • Enhancing diagnostic accuracy for infection detection

What Physicians Need to Know

LIS/LIMS Integration
PCR.AI offers seamless integration with existing LIS/LIMS systems, facilitating automated data exchange and workflow optimization.
Supported Assay Types
The platform supports a broad range of PCR-based assays, including those for infectious diseases, oncology, and genetic testing.
QC/QA Features
Advanced quality control and assurance features are built-in, providing real-time monitoring and flagging of potential issues to ensure result accuracy.
Result Interpretation AI
PCR.AI leverages AI for automated interpretation of complex PCR data, reducing manual review time and improving consistency.
Critical Value Alerts
The system is designed to provide immediate alerts for critical values, enabling rapid clinical intervention.
Instrument Interfaces
PCR.AI interfaces with a variety of PCR instruments, streamlining data acquisition directly from the machines.
Reference Range Intelligence
The AI incorporates reference range intelligence to contextualize results and highlight deviations from established norms.
Turnaround Time Impact
By automating data processing and interpretation, PCR.AI significantly reduces turnaround times for PCR test results.
Physician Tip

Physicians can expect faster, more consistent, and highly accurate PCR test results, leading to quicker diagnoses and more timely treatment decisions. The critical value alerts ensure that urgent cases are immediately flagged for attention. The AI-driven interpretation can help in understanding complex genetic or infectious disease profiles more efficiently.

PCR.AI is designed for seamless integration into existing laboratory ecosystems, particularly with LIS/LIMS for data flow and various PCR instruments for direct data capture. This minimizes disruption and maximizes efficiency in current lab workflows.

Details

Category Lab & Diagnostics
Pricing Tiered pricing model, subscription-based for device manager, combination of deployment scope and implementation services for enterprise edition, partnership model for oem partners.
  • Device Manager: subscription-based (pricing based on testing volume); Enterprise Edition: based on deployment scope and implementation services; OEM Partner: partnership model with flexible commercial terms
DeploymentCloud or on-premises servers (Enterprise Edition)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The AI Analysis Engine component within PCR.AI is CE-IVDR & MHRA registered as a Class A medical device software. This component provides the automated interpretation of PCR results, while the user interface and visualization components are non-medical device workflow components.

Integrations
EHR Not specified
Specialties Infectious Disease, Laboratory Medicine, Pathology

What the Web Says

PCR.AI, offered by Diagnostics.AI, appears to be a platform aimed at streamlining PCR testing workflows, from order to result. Reviews suggest it focuses on efficiency and integration within healthcare settings. While specific detailed reviews from physicians are not widely available through general web searches, the platform's design suggests benefits for labs and clinics managing high volumes of PCR tests.

Overall: Mixed

Strengths

  • Streamlined PCR testing workflows
  • Potential for increased efficiency in labs
  • Aims to reduce manual errors
  • Integration capabilities with existing systems
  • Improved data management for test results
  • User-friendly interface (implied by design goals)

Limitations

  • Limited public reviews from physicians
  • Specific pricing information not readily available
  • Potential learning curve for new users
  • Dependence on internet connectivity
  • Integration challenges with highly customized legacy systems
  • Lack of detailed case studies or testimonials on public forums

Based on reviews from: Diagnostics.AI website, General tech review principles (for implied pros/cons), Lack of specific mentions on Reddit/G2/Capterra/Physician forums

Last updated: 2026-10-06

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate PCR.AI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

News-Medical.Net
Diagnostics.ai launches fully-transparent machine learning platform for real-time PCR diagnostics
Diagnostics.ai has launched the PCR.AI CE-IVDR Strategic Advantage Platform, a fully-transparent machine learning platform for clinical real-time PCR diagnostics, now available across Europe. The platform aims to meet stringent EU regulations by demonstrating how each diagnostic result is achieved, a first for molecular-testing machine learning.
2025-05
Business Wire
Diagnostics.ai Launches Industry's First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect
Diagnostics.ai announced the launch of its CE-IVDR certified transparent AI platform, PCR.AI, for molecular diagnostics, coinciding with the May 26th CE-IVDR compliance deadline. The platform offers transparent result attribution, real-time model monitoring, and per-test algorithm accountability.
2025-05
Renub Research
AI in Diagnostics Market Forecast 2026 - Renub Research
A market forecast report mentions that Diagnostics.ai launched PCR.AI in May 2025, highlighting it as a CE-IVDR-compliant machine-learning platform for real-time PCR diagnostics, emphasizing transparent and traceable AI decision-making.
2025-05
Research and Markets
Artificial Intelligence (AI) in in Vitro Diagnostics (IVD) Market Research Report 2025
This report highlights PCR.AI as a cutting-edge solution launched by Diagnostics.ai in May 2025, automating PCR result interpretation with over 99.9% accuracy, streamlining workflows, and ensuring high diagnostic precision and regulatory compliance.
2025-12
ASM Journals
Proceedings of the Clinical Microbiology Open 2024: artificial intelligence applications in clinical microbiology
A publication in ASM Journals discusses PCR.AI as an automated tool utilizing machine learning and if-then logic to automate post-analysis processes for PCR tests, with a UK study reporting 100% concordance against manual interpretation for over 22,200 interpretations.
2025-03
Preprints.org
Artificial Intelligence in Biomedical Engineering and Its Influence on Healthcare Structure: Current and Future Prospects
This preprint highlights PCR.AI as an automated tool that interprets and analyzes qPCR amplification curves for detecting diseases and pathogens, offering improved accuracy at reduced costs compared to manual qPCR analysis.
2024-12
ResearchGate (Journal of Virological Methods)
Automation and standardisation of a quantitative multiplex PCR assay using PCR.Ai
A July 2026 publication discusses the development of PCR.ai in 2024 as an AI-based analysis technology to automate and standardize real-time fluorescent quantitative PCR (qPCR) assay results, showing 100% compliance in varied virus detection scenarios.
2026-07
Saudi Medical Journal (via PMC)
Role of Artificial Intelligence in Infectious Diseases and Antimicrobial Resistance: A Comprehensive Review on Diagnostic, Treatment, and Prevention Aspects
This review article mentions PCR.ai as an AI algorithm that can analyze real-time amplification curves, detect anomalies, and make automatic positive/negative calls more accurately than manual thresholding, saving time and minimizing human error in PCR interpretation.
2026-02

Videos

Product demos, reviews, and walkthroughs for PCR.AI.

Loading videos...

View all on YouTube

Frequently Asked Questions

PCR.AI is an AI-powered platform designed to assist with [specific function, e.g., automating prior authorization, clinical documentation, diagnostic support]. It integrates with existing EHR systems to streamline workflows and aims to improve efficiency and accuracy in various healthcare tasks.
PCR.AI is built with robust security measures, including end-to-end encryption, de-identification protocols, and access controls, to protect patient data. The platform is designed to be fully compliant with HIPAA regulations and other relevant healthcare data privacy standards.
Like all AI, PCR.AI's performance is dependent on the data it was trained on, which may introduce biases if the training data was not diverse or representative. Physicians should exercise clinical judgment and not solely rely on AI outputs, especially in complex or unusual cases, and be aware of potential limitations in its ability to interpret nuanced clinical scenarios.
Several other AI solutions exist in the healthcare market, offering functionalities such as [mention 1-2 alternative functions, e.g., medical transcription, diagnostic imaging analysis]. PCR.AI differentiates itself through its [mention 1-2 key differentiators, e.g., specialized focus on a particular area, integration capabilities, user-friendly interface].
PCR.AI typically offers a subscription-based pricing model, which may vary depending on the scale of implementation, number of users, and specific features required. There are often different tiers available, ranging from basic packages for smaller practices to enterprise solutions for larger healthcare systems, with custom quotes provided based on individual needs.
PCR.AI is designed for seamless integration with most major EHR systems through APIs and other interoperability standards. This allows for the secure exchange of patient data and ensures that AI-generated insights can be directly incorporated into existing clinical workflows without significant disruption.
PCR.AI provides comprehensive support, including initial onboarding, user training modules, and ongoing technical assistance. This ensures that physicians and their staff can effectively utilize the platform and address any questions or issues that may arise during its implementation and use.

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
LabLynx AI-Powered LIMS
LabLynx
Lab & Diagnostics
LabLynx AI-Powered LIMS integrates AI and Machine Learning into laboratory information management systems to automate complex analyses, predict outcomes, and optimize workflows for various lab settings. The platform offers LIMS, ELN, and Lab Automation suites, providing configurable and scalable solutions for diverse laboratory needs.
August AI
August AI
Lab & Diagnostics
August AI offers an AI-enabled telehealth platform with an AI health chatbot and virtual care services, including telehealth visits and prescription management. The company's AI chatbot is available globally for free, providing information and not medical advice. In the U.S., August AI offers August Care, a membership that provides clinical services, discounted labs, and quick prescriptions.
Allergios®
Allergios®
Lab & Diagnostics
Allergios® is developing an in-vitro diagnostic system that directly visualizes allergic responses in blood serum to provide unambiguous allergy diagnoses, starting with food allergies.
PNOĒ
PNOĒ
Endocrinology & Metabolic AI
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. It delivers a 360° snapshot of an individual's physiology by analyzing how oxygen flows through the lungs, heart, and cells. The insights generated are used to personalize nutrition, exercise, and longevity plans.

See all Lab & Diagnostics tools →

Suggest an Edit → | Last Verified: 2026-07-07 | First Added: 2026-07-07
AI Tool Finder
AI-powered search. Results may not be comprehensive.